NO953555L - Benzoylguanidiner substituert med heterocyklus-N-oksyd, fremgangsmåte for fremstilling, deres anvendelse som medikament eller diagnostikum, medikamenter inneholdende dem samt mellomprodukter for deres fremstilling - Google Patents
Benzoylguanidiner substituert med heterocyklus-N-oksyd, fremgangsmåte for fremstilling, deres anvendelse som medikament eller diagnostikum, medikamenter inneholdende dem samt mellomprodukter for deres fremstillingInfo
- Publication number
- NO953555L NO953555L NO953555A NO953555A NO953555L NO 953555 L NO953555 L NO 953555L NO 953555 A NO953555 A NO 953555A NO 953555 A NO953555 A NO 953555A NO 953555 L NO953555 L NO 953555L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- opt
- preparation
- ome
- oxide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
- C07D215/60—N-oxides
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4432106A DE4432106A1 (de) | 1994-09-09 | 1994-09-09 | Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung |
Publications (3)
Publication Number | Publication Date |
---|---|
NO953555D0 NO953555D0 (no) | 1995-09-08 |
NO953555L true NO953555L (no) | 1996-03-11 |
NO305202B1 NO305202B1 (no) | 1999-04-19 |
Family
ID=6527788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO953555A NO305202B1 (no) | 1994-09-09 | 1995-09-08 | Benzoylguanidiner, mellomprodukter for fremstilling derav, guanidinenes anvendelse og legemidler inneholdende guanidinene |
Country Status (22)
Country | Link |
---|---|
US (1) | US5641792A (no) |
EP (1) | EP0700904B1 (no) |
JP (1) | JP4113262B2 (no) |
KR (1) | KR960010619A (no) |
CN (1) | CN1119643A (no) |
AT (1) | ATE210121T1 (no) |
AU (1) | AU695342B2 (no) |
CA (1) | CA2157855C (no) |
CZ (1) | CZ291188B6 (no) |
DE (2) | DE4432106A1 (no) |
DK (1) | DK0700904T3 (no) |
ES (1) | ES2168324T3 (no) |
FI (1) | FI954190A (no) |
HU (1) | HU219976B (no) |
IL (1) | IL115196A (no) |
NO (1) | NO305202B1 (no) |
NZ (1) | NZ272946A (no) |
PL (1) | PL310346A1 (no) |
PT (1) | PT700904E (no) |
RU (1) | RU2160727C2 (no) |
SI (1) | SI9500280B (no) |
ZA (1) | ZA957548B (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0765867A1 (de) * | 1995-09-27 | 1997-04-02 | Hoechst Aktiengesellschaft | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament |
DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19542306A1 (de) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
PL316439A1 (en) * | 1995-11-20 | 1997-05-26 | Hoechst Ag | Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such |
DE19546736A1 (de) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate |
DE19621319A1 (de) * | 1996-05-28 | 1997-12-04 | Hoechst Ag | Bis-ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19737224A1 (de) | 1997-08-27 | 1999-03-18 | Hoechst Marion Roussel De Gmbh | Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen |
US6852739B1 (en) * | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
US6455554B1 (en) | 1999-06-07 | 2002-09-24 | Targacept, Inc. | Oxopyridinyl pharmaceutical compositions and methods for use |
CA2493618A1 (en) * | 2002-08-01 | 2004-02-12 | Nitromed, Inc. | Nitrosated proton pump inhibitors, compositions and methods of use |
WO2006055404A2 (en) * | 2004-11-16 | 2006-05-26 | Merck & Co., Inc. | Compounds for targeting mechanisms implicated in the progression of stroke |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE271903C (no) * | ||||
US3780027A (en) | 1970-04-29 | 1973-12-18 | Merck & Co Inc | Anthranilic acid derivatives |
DE2258276C3 (de) * | 1972-11-28 | 1981-08-13 | Bayer Ag, 5090 Leverkusen | Triazolyl-stilbene, sowie deren Herstellung und Verwendung als optische Aufheller |
US3931181A (en) * | 1973-07-27 | 1976-01-06 | Hoffmann-La Roche Inc. | 2,4-Diamino-5-benzylpyrimidines |
JPS59510B2 (ja) * | 1973-11-22 | 1984-01-07 | 塩野義製薬株式会社 | ピリジンユウドウタイ ノ セイゾウホウ |
US4373024A (en) | 1980-12-02 | 1983-02-08 | Phillips Petroleum Company | Apparatus useful for foam breaking |
US4617307A (en) * | 1984-06-20 | 1986-10-14 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors |
DD271903A1 (de) * | 1988-05-17 | 1989-09-20 | Univ Halle Wittenberg | Verfahren zur herstellung stabiler, 2-unsubstituierter imidazol-3-oxide |
US4959377A (en) * | 1989-06-29 | 1990-09-25 | Hoechst-Roussel Pharmaceuticals Inc. | Phenoxypyridinamine compounds which are use as a dermatological composition |
DE3929582A1 (de) | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
US5212182A (en) * | 1990-10-03 | 1993-05-18 | American Home Products Corpooration | Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics |
ES2089600T3 (es) * | 1992-02-15 | 1996-10-01 | Hoechst Ag | Benzoilguanidina sustituida en 3,5, con efecto antiarritmico y efecto inhibidor de la proliferacion de celulas. |
TW250479B (no) * | 1992-12-15 | 1995-07-01 | Hoechst Ag |
-
1994
- 1994-09-09 DE DE4432106A patent/DE4432106A1/de not_active Withdrawn
-
1995
- 1995-09-04 AT AT95113845T patent/ATE210121T1/de not_active IP Right Cessation
- 1995-09-04 ES ES95113845T patent/ES2168324T3/es not_active Expired - Lifetime
- 1995-09-04 EP EP95113845A patent/EP0700904B1/de not_active Expired - Lifetime
- 1995-09-04 PT PT95113845T patent/PT700904E/pt unknown
- 1995-09-04 DE DE59509899T patent/DE59509899D1/de not_active Expired - Lifetime
- 1995-09-04 DK DK95113845T patent/DK0700904T3/da active
- 1995-09-06 CN CN95116297A patent/CN1119643A/zh active Pending
- 1995-09-06 IL IL11519695A patent/IL115196A/xx active IP Right Grant
- 1995-09-07 FI FI954190A patent/FI954190A/fi unknown
- 1995-09-07 NZ NZ272946A patent/NZ272946A/en unknown
- 1995-09-07 KR KR1019950029358A patent/KR960010619A/ko not_active Application Discontinuation
- 1995-09-07 RU RU95115511/04A patent/RU2160727C2/ru not_active IP Right Cessation
- 1995-09-07 AU AU30504/95A patent/AU695342B2/en not_active Ceased
- 1995-09-08 PL PL95310346A patent/PL310346A1/xx unknown
- 1995-09-08 CA CA002157855A patent/CA2157855C/en not_active Expired - Fee Related
- 1995-09-08 SI SI9500280A patent/SI9500280B/sl unknown
- 1995-09-08 ZA ZA957548A patent/ZA957548B/xx unknown
- 1995-09-08 NO NO953555A patent/NO305202B1/no unknown
- 1995-09-08 US US08/525,156 patent/US5641792A/en not_active Expired - Lifetime
- 1995-09-08 HU HU9502634A patent/HU219976B/hu not_active IP Right Cessation
- 1995-09-08 CZ CZ19952315A patent/CZ291188B6/cs not_active IP Right Cessation
- 1995-09-08 JP JP23096695A patent/JP4113262B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CZ231595A3 (en) | 1996-04-17 |
NO953555D0 (no) | 1995-09-08 |
AU695342B2 (en) | 1998-08-13 |
HUT72630A (en) | 1996-05-28 |
PL310346A1 (en) | 1996-03-18 |
PT700904E (pt) | 2002-05-31 |
NZ272946A (en) | 1996-12-20 |
RU2160727C2 (ru) | 2000-12-20 |
US5641792A (en) | 1997-06-24 |
ES2168324T3 (es) | 2002-06-16 |
ATE210121T1 (de) | 2001-12-15 |
HU219976B (hu) | 2001-10-28 |
CA2157855A1 (en) | 1996-03-10 |
IL115196A0 (en) | 1995-12-31 |
SI9500280B (en) | 2001-12-31 |
KR960010619A (ko) | 1996-04-20 |
FI954190A (fi) | 1996-03-10 |
EP0700904B1 (de) | 2001-12-05 |
NO305202B1 (no) | 1999-04-19 |
FI954190A0 (fi) | 1995-09-07 |
ZA957548B (en) | 1996-04-17 |
DE4432106A1 (de) | 1996-03-14 |
CZ291188B6 (cs) | 2003-01-15 |
JP4113262B2 (ja) | 2008-07-09 |
CA2157855C (en) | 2009-04-21 |
DK0700904T3 (da) | 2002-03-18 |
JPH0892215A (ja) | 1996-04-09 |
CN1119643A (zh) | 1996-04-03 |
EP0700904A1 (de) | 1996-03-13 |
HU9502634D0 (en) | 1995-11-28 |
SI9500280A (en) | 1996-04-30 |
AU3050495A (en) | 1996-03-21 |
IL115196A (en) | 2003-01-12 |
DE59509899D1 (de) | 2002-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO953555L (no) | Benzoylguanidiner substituert med heterocyklus-N-oksyd, fremgangsmåte for fremstilling, deres anvendelse som medikament eller diagnostikum, medikamenter inneholdende dem samt mellomprodukter for deres fremstilling | |
KR870000918A (ko) | 제약적 투여단위 | |
NO953553D0 (no) | Aminosyresubstituerte benzoylguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende dem | |
ES8604981A1 (es) | Un procedimiento para preparar derivados de acido griseolico | |
GB1257225A (no) | ||
GR3033049T3 (en) | Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use as medicament or diagnostic agent, as well as medicaments containing them | |
GB2199746A (en) | Antibiotic compositions | |
JO1629B1 (en) | Andadnodol compounds i | |
IE48254B1 (en) | Stabilized aqueous parenteral antibiotic compositions and a process for their preparation | |
US3198788A (en) | N-methylol-alpha-aminobenzyl-penicillin | |
US4301160A (en) | Ready for use, injectable, aqueous solutions of alkali metal salts of canrenoic acid and furosemide and process for their preparation | |
ES8607319A1 (es) | "un procedimiento para la preparacion de un derivado de ce- falosporina" | |
Blair et al. | The effect of actinomycin, clavacin, and tyrothricin on staphylococcal toxin | |
JPH06700B2 (ja) | 安定な水性液剤 | |
US2750325A (en) | Injectable erythromycin preparations | |
GB1065617A (en) | Nitrofuran derivatives | |
GB1274553A (en) | Hydroxyalkylene-substituted benzoxazines and benzothiazines | |
IE38725B1 (en) | Pyrimidopyrimidines | |
DK400385A (da) | Arphameninderivater, fremgangsmaade til deres fremstilling samt anvendelse heraf som laegemiddel |